Lugongolo, Masixole YManoto, Sello LOmbinda-Lemboumba, SaturninMaaza, MMthunzi-Kufa, Patience2022-05-092022-05-092020-06Lugongolo, M.Y., Manoto, S.L., Ombinda-Lemboumba, S., Maaza, M. & Mthunzi-Kufa, P. 2020. The combination of low level laser therapy and efavirenz drastically reduces HIV infection in TZM-bl cells. <i>Biomedical Journal.</i> http://hdl.handle.net/10204/124052319-41702320-2890doi.org/10.1016/j.bj.2020.05.022http://hdl.handle.net/10204/12405Human immunodeficiency virus (HIV) infection remains a global health challenge despite the use of antiretroviral therapy, which has led to a significant decline in the mortality rates. Owing to the unavailability of an effective treatment to completely eradicate the virus, researchers continue to explore new methods. Low level laser therapy (LLLT) has been widely used to treat different medical conditions and involves the exposure of cells or tissues to low levels of red and near infrared light. The study aimed to determine the effect of combining two unrelated therapies on HIV infection in TZM-bl cells.FulltextenLow level laser therapyHuman immunodeficiency virusTZM-bl cellsInfectedUninfectedIrradiationArticleLugongolo, M. Y., Manoto, S. L., Ombinda-Lemboumba, S., Maaza, M., & Mthunzi-Kufa, P. (2020). The combination of low level laser therapy and efavirenz drastically reduces HIV infection in TZM-bl cells. <i>Biomedical Journal</i>, http://hdl.handle.net/10204/12405Lugongolo, Masixole Y, Sello L Manoto, Saturnin Ombinda-Lemboumba, M Maaza, and Patience Mthunzi-Kufa "The combination of low level laser therapy and efavirenz drastically reduces HIV infection in TZM-bl cells." <i>Biomedical Journal</i> (2020) http://hdl.handle.net/10204/12405Lugongolo MY, Manoto SL, Ombinda-Lemboumba S, Maaza M, Mthunzi-Kufa P. The combination of low level laser therapy and efavirenz drastically reduces HIV infection in TZM-bl cells. Biomedical Journal. 2020; http://hdl.handle.net/10204/12405.TY - Article AU - Lugongolo, Masixole Y AU - Manoto, Sello L AU - Ombinda-Lemboumba, Saturnin AU - Maaza, M AU - Mthunzi-Kufa, Patience AB - Human immunodeficiency virus (HIV) infection remains a global health challenge despite the use of antiretroviral therapy, which has led to a significant decline in the mortality rates. Owing to the unavailability of an effective treatment to completely eradicate the virus, researchers continue to explore new methods. Low level laser therapy (LLLT) has been widely used to treat different medical conditions and involves the exposure of cells or tissues to low levels of red and near infrared light. The study aimed to determine the effect of combining two unrelated therapies on HIV infection in TZM-bl cells. DA - 2020-06 DB - ResearchSpace DP - CSIR J1 - Biomedical Journal KW - Low level laser therapy KW - Human immunodeficiency virus KW - TZM-bl cells KW - Infected KW - Uninfected KW - Irradiation LK - https://researchspace.csir.co.za PY - 2020 SM - 2319-4170 SM - 2320-2890 T1 - The combination of low level laser therapy and efavirenz drastically reduces HIV infection in TZM-bl cells TI - The combination of low level laser therapy and efavirenz drastically reduces HIV infection in TZM-bl cells UR - http://hdl.handle.net/10204/12405 ER -23711